These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8973047)

  • 1. Edmonton injector: use in Córdoba, Argentina.
    Pruvost M; De la Colina OE; Monasterolo NA
    J Pain Symptom Manage; 1996 Dec; 12(6):372-5. PubMed ID: 8973047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose oral morphine in cancer pain management: a report of twelve cases.
    Radbruch L; Grond S; Zech DJ; Bischoff A
    J Clin Anesth; 1996 Mar; 8(2):144-50. PubMed ID: 8695098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain.
    Gagnon B; Bielech M; Watanabe S; Walker P; Hanson J; Bruera E
    Support Care Cancer; 1999 Jul; 7(4):265-70. PubMed ID: 10423053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
    Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
    J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of an implantable drug delivery system.
    Davis MP; Walsh D; Lagman R; LeGrand SB
    J Clin Oncol; 2003 Jul; 21(14):2800-1; author reply 2802-3. PubMed ID: 12860958
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature.
    Gilmer-Hill HS; Boggan JE; Smith KA; Wagner FC
    Surg Neurol; 1999 Jan; 51(1):12-5. PubMed ID: 9952117
    [No Abstract]   [Full Text] [Related]  

  • 7. The Edmonton injector: a simple device for patient-controlled subcutaneous analgesia.
    Bruera E; MacMillan K; Hanson J; MacDonald NR
    Pain; 1991 Feb; 44(2):167-169. PubMed ID: 2052383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine.
    Sabatowski R; Kasper SM; Radbruch L
    J Pain Symptom Manage; 2002 Jan; 23(1):3-5. PubMed ID: 11779660
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.
    Glare P; Walsh D; Groh E; Nelson KA
    Am J Hosp Palliat Care; 2002; 19(5):343-50. PubMed ID: 12269781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
    Wong CS; Chang YC; Yeh CC; Huang GS; Cherng CH
    Can J Anaesth; 2002; 49(6):561-5. PubMed ID: 12067866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strong opioids].
    Furuyama Y; Yamamuro M
    Nihon Rinsho; 2001 Sep; 59(9):1783-8. PubMed ID: 11554052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on Ripamonti et al., Pain, 70 (1997) 109-115.
    Morley JS; Makin MK
    Pain; 1997 Oct; 73(1):114-5. PubMed ID: 9414068
    [No Abstract]   [Full Text] [Related]  

  • 14. Nurse-controlled analgesia using a patient-controlled analgesia device: an alternative strategy in the management of severe cancer pain in children.
    Kanagasundaram SA; Cooper MG; Lane LJ
    J Paediatr Child Health; 1997 Aug; 33(4):352-5. PubMed ID: 9323628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
    Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
    J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular administration of morphine and clonidine.
    Leong MS; Calabrese JF; Heit G
    Anesthesiology; 2001 Jun; 94(6):1141-3. PubMed ID: 11465609
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
    Anderson VC; Burchiel KJ
    Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
    Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.